Naproxen/Esomeprazol 1a Pharma (Esomeprazole, Naproxen)

Naproxen/Esomeprazol is indicated for conditions where inflammation and pain coexist with a risk of gastric irritation.

• Osteoarthritis: reduces joint pain and improves mobility while protecting the stomach lining.
• Rheumatoid arthritis: alleviates chronic joint inflammation and pain with ulcer prophylaxis.
• Acute musculoskeletal injury: provides rapid analgesia and anti‑inflammatory effect with reduced ulcer risk.
• Post‑operative pain: manages postoperative discomfort while minimizing gastric side effects.
• NSAID‑induced ulcer prophylaxis: prevents gastric ulcer formation in patients requiring long‑term NSAID therapy.

• Naproxen non‑selectively inhibits cyclo‑oxygenase‑1 and cyclo‑oxygenase‑2 enzymes, decreasing prostaglandin synthesis and thereby reducing pain and inflammation. Esomeprazole irreversibly binds to the gastric H+/K+‑ATPase pump on parietal cells, suppressing gastric acid secretion and providing gastro‑protective effect. The combined action allows effective analgesia with reduced risk of NSAID‑related gastric injury.

Common Side Effects

• Dyspepsia: mild stomach discomfort or indigestion.
• Headache: transient tension‑type headache.
• Nausea: occasional feeling of queasiness.
• Dizziness: light‑headed sensation, especially on standing.

Serious or Rare Side Effects

• Gastrointestinal bleeding: signs include black stools or vomiting blood.
• Severe allergic reaction: rash, swelling, or difficulty breathing.
• Liver enzyme elevation: abnormal liver function tests.
• Kidney impairment: reduced urine output or swelling of limbs.

Before prescribing Naproxen/Esomeprazol, clinicians should consider patient‑specific risk factors and monitor for adverse events.

• Assess renal function: avoid in severe renal impairment.
• Monitor for gastrointestinal bleeding: especially in patients with a history of ulcers.
• Use lowest effective dose: limit duration to the shortest necessary period.
• Avoid in known hypersensitivity: discontinue if allergic reactions occur.
• Review concomitant anticoagulant use: increased bleeding risk.
• Store at room temperature: keep in the original pack, protect from moisture.

Naproxen/Esomeprazol may interact with several drug classes; careful assessment is required.

Major Interactions (Avoid)

• Concurrent NSAIDs: additive gastrointestinal toxicity.
• Anticoagulants (e.g., warfarin): heightened risk of serious bleeding.

Moderate Interactions (Monitor Closely)

• Antihypertensives: possible reduction in blood pressure control.
• Diuretics: increased risk of renal dysfunction.
• Lithium: potential elevation of lithium serum levels.
• Methotrexate: enhanced methotrexate toxicity.